CD163 and pulmonary fibrosis: M2‐like macrophage markers (CD163 and CD204) and CD163/CD68 and CD204/CD68 cell ratios are significantly elevated in idiopathic pulmonary fibrosis (IPF) patients, associating with shorter overall survival and time‐to‐acute exacerbation in IPF patients.59